Clinical Trial Update: Oral Curcumin for Radiation Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports results from Phase 2 and Phase 3 studies of oral curcumin for radiation-induced dermatitis, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Dermatitis

Drugs mentioned

• Curcumin (oral) (curcumin)

Snippet

Sponsor: University of Rochester | Conditions: Radiation-induced Dermatitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-07